SCHEMBL9532065

SCHEMBL9532065

CC#CCc1cn(CCC(C)C)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.44

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 4/20 0.44
AGTR2 P50052 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9553874 0.92 AGTR1 (0.42) AGTR1AGTR2
SCHEMBL9553512 0.91 AGTR1 (0.50) AGTR1AGTR2
SCHEMBL9532744 0.89 AGTR1 (0.57) AGTR1AGTR2
SCHEMBL9554023 0.89 AGTR1 (0.47) AGTR1AGTR2
SCHEMBL9554383 0.89 AGTR1 (0.47) AGTR1AGTR2
SCHEMBL9554508 0.89 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL9553784 0.89 AGTR1 (0.43) AGTR1AGTR2
SCHEMBL9534559 0.89 AGTR1 (0.45) AGTR1AGTR2
SCHEMBL9554037 0.89 AGTR1 (0.51) AGTR1AGTR2
SCHEMBL9530714 0.89 AGTR1 (0.43) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0251086-B1 ANTIFUNGAL CARBINOLS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-03-17 EP claimed
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
EP-0555331-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS. SEARLE & CO (US) 1993-08-18 EP disclosed
WO-1992007834-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed